Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06675357
PHASE2

Using FAPI PET/MRI to Evaluate Prostate Cancer

Sponsor: University of Wisconsin, Madison

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to gain more information about how FAPI (fibroblast activation protein inhibitor) binds to certain type of cells in the tumor tissue. The main question it aims to answer is how this information can be used to better diagnose and track prostate cancer. Participants will undergo two PET/MRI scans during two research visits, each of which may last up to 2.5 hours.

Official title: Novel FAP-targeted Approach to Imaging Patients With or High-risk for Metastatic Prostate Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-02-27

Completion Date

2027-01

Last Updated

2026-03-04

Healthy Volunteers

No

Interventions

RADIATION

FAPI

5 +/- 2 mCi of Ga-FAPI-46

PROCEDURE

Positron Emission Tomography (PET)

Undergo PET scan

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI scan

Locations (1)

University of Wisconsin

Madison, Wisconsin, United States